277 related articles for article (PubMed ID: 28243990)
1. Associations between single-nucleotide polymorphisms and inflammatory bowel disease-associated colorectal cancers in inflammatory bowel disease patients: a meta-analysis.
Li H; Jin Z; Li X; Wu L; Jin J
Clin Transl Oncol; 2017 Aug; 19(8):1018-1027. PubMed ID: 28243990
[TBL] [Abstract][Full Text] [Related]
2. Ulcerative colitis neoplasia is not associated with common inflammatory bowel disease single-nucleotide polymorphisms.
Connelly TM; Berg AS; Harris LR; Brinton DL; Hegarty JP; Deiling SM; Stewart DB; Koltun WA
Surgery; 2014 Aug; 156(2):253-62. PubMed ID: 24947639
[TBL] [Abstract][Full Text] [Related]
3. TNF-α-308G/A polymorphism and the risk of colorectal cancer: A systematic review and an updated meta-analysis.
Miao Z; Wang K; Wang X; Zhang C; Xu Y
J BUON; 2018; 23(6):1616-1624. PubMed ID: 30610785
[TBL] [Abstract][Full Text] [Related]
4. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
[TBL] [Abstract][Full Text] [Related]
5. Chemopreventive effects of 5-aminosalicylic acid on inflammatory bowel disease-associated colorectal cancer and dysplasia: a systematic review with meta-analysis.
Qiu X; Ma J; Wang K; Zhang H
Oncotarget; 2017 Jan; 8(1):1031-1045. PubMed ID: 27906680
[TBL] [Abstract][Full Text] [Related]
6. Colorectal cancer in inflammatory bowel diseases: a population-based study (1976-2008).
Peyrin-Biroulet L; Lepage C; Jooste V; Guéant JL; Faivre J; Bouvier AM
Inflamm Bowel Dis; 2012 Dec; 18(12):2247-51. PubMed ID: 22467511
[TBL] [Abstract][Full Text] [Related]
7. Associations of single nucleotide polymorphisms in miR-146a, miR-196a, miR-149 and miR-499 with colorectal cancer susceptibility.
Du W; Ma XL; Zhao C; Liu T; Du YL; Kong WQ; Wei BL; Yu JY; Li YY; Huang JW; Li ZK; Liu L
Asian Pac J Cancer Prev; 2014; 15(2):1047-55. PubMed ID: 24568449
[TBL] [Abstract][Full Text] [Related]
8. Single Nucleotide Polymorphisms in Colitis-Associated Colorectal Cancer: A Current Overview with Emphasis on the Role of the Associated Genes Products.
Makaro A; Fichna J; Włodarczyk M
Curr Drug Targets; 2020; 21(14):1456-1462. PubMed ID: 32718287
[TBL] [Abstract][Full Text] [Related]
9. Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease.
Beaugerie L; Svrcek M; Seksik P; Bouvier AM; Simon T; Allez M; Brixi H; Gornet JM; Altwegg R; Beau P; Duclos B; Bourreille A; Faivre J; Peyrin-Biroulet L; Fléjou JF; Carrat F;
Gastroenterology; 2013 Jul; 145(1):166-175.e8. PubMed ID: 23541909
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in non-coding RNAs and risk of colorectal cancer: A systematic review and meta-analysis.
Alidoust M; Hamzehzadeh L; Rivandi M; Pasdar A
Crit Rev Oncol Hematol; 2018 Dec; 132():100-110. PubMed ID: 30447914
[TBL] [Abstract][Full Text] [Related]
11. Relationship between the polymorphism of tumor necrosis factor-α-308 G>A and susceptibility to inflammatory bowel diseases and colorectal cancer: a meta-analysis.
Fan W; Maoqing W; Wangyang C; Fulan H; Dandan L; Jiaojiao R; Xinshu D; Binbin C; Yashuang Z
Eur J Hum Genet; 2011 Apr; 19(4):432-7. PubMed ID: 21248737
[TBL] [Abstract][Full Text] [Related]
12. Survival of Colorectal Cancer in Patients With or Without Inflammatory Bowel Disease: A Meta-Analysis.
Ou B; Zhao J; Guan S; Lu A
Dig Dis Sci; 2016 Mar; 61(3):881-9. PubMed ID: 26518415
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory bowel disease and risk of gastric, small bowel and colorectal cancer: a meta-analysis of 26 observational studies.
Wan Q; Zhao R; Xia L; Wu Y; Zhou Y; Wang Y; Cui Y; Shen X; Wu XT
J Cancer Res Clin Oncol; 2021 Apr; 147(4):1077-1087. PubMed ID: 33433655
[TBL] [Abstract][Full Text] [Related]
14. Risk of Early Colorectal Cancers Needs to Be Considered in Inflammatory Bowel Disease Care.
Cohen-Mekelburg S; Schneider Y; Gold S; Ghosh G; Rosenblatt R; Hajifathalian K; Scherl E; Schnoll-Sussman F; Katz P; Steinlauf A
Dig Dis Sci; 2019 Aug; 64(8):2273-2279. PubMed ID: 30815820
[TBL] [Abstract][Full Text] [Related]
15. Family history as a risk factor for colorectal cancer in inflammatory bowel disease.
Askling J; Dickman PW; Karlén P; Broström O; Lapidus A; Löfberg R; Ekbom A
Gastroenterology; 2001 May; 120(6):1356-62. PubMed ID: 11313305
[TBL] [Abstract][Full Text] [Related]
16. Morphological, immunohistochemical and molecular features of inflammatory bowel disease associated colorectal carcinoma and associated mucosal lesions - Single institution experience.
Kamarádová K; Vošmiková H; Rozkošová K; Ryška A; Tachecí I; Laco J
Pathol Res Pract; 2019 Apr; 215(4):730-737. PubMed ID: 30679085
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory bowel disease in Ashkenazi Jews: implications for familial colorectal cancer.
Lynch HT; Brand RE; Locker GY
Fam Cancer; 2004; 3(3-4):229-32. PubMed ID: 15516846
[TBL] [Abstract][Full Text] [Related]
18. KRAS and TP53 mutations in inflammatory bowel disease-associated colorectal cancer: a meta-analysis.
Du L; Kim JJ; Shen J; Chen B; Dai N
Oncotarget; 2017 Mar; 8(13):22175-22186. PubMed ID: 28077799
[TBL] [Abstract][Full Text] [Related]
19. Survival Outcomes and Clinicopathological Features in Inflammatory Bowel Disease-associated Colorectal Cancer: A Systematic Review and Meta-analysis.
Lu C; Schardey J; Zhang T; Crispin A; Wirth U; Karcz KW; Bazhin AV; Andrassy J; Werner J; Kühn F
Ann Surg; 2022 Nov; 276(5):e319-e330. PubMed ID: 34913897
[TBL] [Abstract][Full Text] [Related]
20. Associations between CD24 gene polymorphisms and inflammatory bowel disease: A meta-analysis.
Huang XL; Xu DH; Wang GP; Zhang S; Yu CG
World J Gastroenterol; 2015 May; 21(19):6052-9. PubMed ID: 26019472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
